Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF et al (2019) Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain 142(9):2558–2571
Article PubMed PubMed Central Google Scholar
Braak H, del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Castellanos G, Fernández-Seara MA, Lorenzo-Betancor O, Ortega-Cubero S, Puigvert M, Uranga J et al (2015) Automated neuromelanin imaging as a diagnostic biomarker for Parkinson’s disease. Mov Disord 30(7):945–952
Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715–725
Article PubMed PubMed Central Google Scholar
Coon EA (2020) Autonomic Dysfunction in the Synucleinopathies. Semin Neurol 40(5):492–501
Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33(3):349–358
Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus norepinephrine system and related circuitry in Parkinson’s disease-related dementia. J Neurol Neurosurg Psychiatry 84(7):774–783
Doppler CEJ, Kinnerup MB, Brune C, Farrher E, Betts M, Fedorova TD et al (2021) Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson’s disease. Brain 144(9):2732–2744
Ehrminger M, Latimier A, Pyatigorskaya N, Garcia-Lorenzo D, Leu-Semenescu S, Vidailhet M et al (2016) The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behavior disorder. Brain 139(4):1180–1188
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1837
Espay AJ, LeWitt PA, Kaufmann H (2014) Norepinephrine deficiency in Parkinson’s disease: the case for noradrenergic enhancement. Mov Disord 29(14):1710–1719
Article CAS PubMed Google Scholar
Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149(2):351–356
Article CAS PubMed Google Scholar
Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol 72(8):863–873
Fernandes P, Regala J, Correia F, Gonçalves-Ferreira AJ (2012) The human locus coeruleus 3-D stereotactic anatomy. Surg Radiol Anat 34(10):879–885
Article CAS PubMed Google Scholar
Galgani A, Lombardo F, Della Latta D, Martini N, Bonuccelli U, Fornai F, Giorgi FS (2020) Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases. Curr Neurol Neurosci Rep 21(1):2
Article PubMed PubMed Central Google Scholar
Galgani A, Lombardo F, Martini N, Vergallo A, Bastiani L, Hampel H et al (2023) Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia. Eur J Neurol 30(1):32–46
García-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C et al (2013) The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain 136(7):2120–2129
Article PubMed PubMed Central Google Scholar
German DC, Manaye KF, White CL 3rd, Woodward DJ, McIntire DD, Smith WK et al (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676
Article CAS PubMed Google Scholar
Giorgi FS, Galgani A, Puglisi-Allegra S, Busceti CL, Fornai F (2021) The connections of Locus Coeruleus with hypothalamus: potential involvement in Alzheimer’s disease. J Neural Transm (vienna) 128(5):589–613
Article CAS PubMed Google Scholar
Giorgi FS, Martini N, Lombardo F, Galgani A, Bastiani L, Della Latta D et al (2022) Locus Coeruleus magnetic resonance imaging: a comparison between native-space and template-space approach. J Neural Transm (vienna) 29(4):387–394
Guaraldi P, Baschieri F, Barletta G, Cecere A, Cortelli P, Calandra-Buonaura G (2020) Validation of the new index of baroreflex function to identify neurogenic orthostatic hypotension. Auton Neurosci 229:102744
Helmich RC, Lehéricy S (2021) Dying-back of ascending noradrenergic projections in Parkinson’s disease. Brain 144(9):2562–2564
Article PubMed PubMed Central Google Scholar
Iranzo A, Gelpi E, Tolosa E, Molinuevo JL, Serradell M, Gaig C, Santamaria J (2014) Neuropathology of prodromal Lewy body disease. Mov Disord 29(3):410–415
Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G et al (2016) Neuromelanin imaging and dopaminergic loss in Parkinson’s disease. Front Aging Neurosci 8:196
Article PubMed PubMed Central Google Scholar
Jain S, Goldstein DS (2012) Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 46(3):572–580
Article CAS PubMed Google Scholar
Kelberman M, Keilholz S, Weinshenker D (2020) What’s That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease. Front Neurosci 14:583421
Article PubMed PubMed Central Google Scholar
Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm ACE, Aston-Jones GS et al (2015) Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. Neuroimage 113:235–245
Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Otto M, Svendsen KB et al (2018) In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol 17(7):618–628
Li Y, Wang C, Wang J, Zhou Y, Ye F, Zhang Y et al (2019) Mild cognitive impairment in de novo Parkinson’s disease: A neuromelanin MRI study in locus coeruleus. Mov Disord 34(6):884–892
Madelung CF, Meder D, Fuglsang SA, Marques MM, Boer VO, Madsen KH et al (2022) Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson’s Disease. Mov Disord 37(3):479–489
Article CAS PubMed PubMed Central Google Scholar
Malatt C, Tagliati M (2022) The role of the locus coeruleus/norepinephrine system in the pathogenesis of neurodegenerative disorders: An update. Curr Opin Neurol 35(2):220–229
Article CAS PubMed Google Scholar
Norcliffe-Kaufmann L, Kaufmann H, Palma JA, Shibao CA, Biaggioni I, Peltier AC et al (2018) Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol 83(3):522–531
Article PubMed PubMed Central Google Scholar
Oertel WH, Henrich MT, Janzen A, Geibl FF (2019) The locus coeruleus: Another vulnerability target in Parkinson’s disease. Mov Disord 34(10):1423–1429
Ohtsuka C, Sasaki M, Konno K, Kato K, Takahashi J, Yamashita F et al (2014) Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord 20(7):755–760
Paredes-Rodriguez E, Vegas-Suarez S, Morera-Herreras T, De Deurwaerdere P, Miguelez C (2020) The Noradrenergic System in Parkinson’s Disease. Front Pharmacol 11:435
Article CAS PubMed PubMed Central Google Scholar
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G et al (2020) Locus coeruleus: a new look at the blue spot. Nat Rev Neurosci 21(11):644–659
Article CAS PubMed PubMed Central Google Scholar
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601
Prasuhn J, Prasuhn M, Fellbrich A, Strautz R, Lemmer F, Dreischmeier S et al (2021) Association of locus coeruleus and substantia nigra pathology with cognitive and motor functions in patients with Parkinson disease. Neurology 97:e1007–e1016
Article CAS PubMed Google Scholar
Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128(6):1314–1322
Comments (0)